LOXL2 and non-small cell lung carcinoma: In the GEPIA database, we found that the expression levels of RTKN2, NFIX, PTX3 and BMP2 in NSCLC subtypes LUAD and LUSC tissues were significantly declined, while the expression of LOXL2 in NSCLC tissues increased (Figure S3).